Cargando…

LERONLIMAB AND THE ROLE OF CCR5 SUPRESSION IN COVID-19 TREATMENT

Detalles Bibliográficos
Autores principales:	BJORK, SARAH, MINKIN, RUTH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Chest Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503312/ http://dx.doi.org/10.1016/j.chest.2021.07.445

Ejemplares similares

SEVERE ADENOVIRUS PNEUMONIA IN RITUXIMAB INFUSIONS
por: BJORK, SARAH, et al.
Publicado: (2021)

EOSINOPHILS AND IL-5 RECEPTOR IN COVID-19 POSTMORTEM LUNG TISSUE
por: MCCRAE, CHRISTOPHER, et al.
Publicado: (2021)

ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA
por: KUMAR, MYTHRI ANIL, et al.
Publicado: (2022)

ROLE OF HONEY AND NIGELLA SATIVA IN THE MANAGEMENT OF COVID-19: HNS-COVID-PK TRIAL
por: FAROOQ, I., et al.
Publicado: (2022)

CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab
por: Chang, Xiao L., et al.
Publicado: (2021)

A CASE OF DISSEMINATED STRONGYLOIDIASIS DURING TREATMENT FOR COVID-19
por: PATEL, ANJALI, et al.
Publicado: (2021)

DECODING COVID-19: A NOVEL ROLE OF ANTITHROMBIN DEFICIENCY IN THE NOVEL CORONAVIRUS
por: Mills, Krystal, et al.
Publicado: (2020)

PULMONARY ASPERGILLOSIS POST-TOCILIZUMAB TREATMENT IN A PATIENT WITH COVID-19 PNEUMONIA
por: GIDWANI, VIPUL, et al.
Publicado: (2022)

COVID-19 PNEUMONIA COMPLICATED BY CMV PNEUMONITIS FOLLOWING TREATMENT WITH AN IL-6 INHIBITOR
por: PANDIAN, ELIZABETH, et al.
Publicado: (2021)

INHALED PULMONARY VASODILATOR TREATMENT FOR COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: BERAN BERAN, AZIZULLAH, et al.
Publicado: (2021)

Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species
por: Chang, Xiao L., et al.
Publicado: (2022)

PROCALCITONIN AS A PREDICTOR OF CLINICAL OUTCOMES IN PATIENTS WITH COVID-19
por: JACKSON, IAN, et al.
Publicado: (2021)

POTENTIAL ROLE OF A SINGLE NUCLEOTIDE POLYMORPHISM OF NOD-LIKE RECEPTOR-X1 IN COVID-19 SUSCEPTIBILITY
por: DEEPAK, V., et al.
Publicado: (2022)

EXPERIENCE WITH REMDESIVIR FOR THE TREATMENT OF CRITICAL COVID-19 IN A COMMUNITY-BASED HOSPITAL IN EVANSTON, ILLINOIS
por: EGORYAN, GOAR, et al.
Publicado: (2021)

PLASMA EXCHANGE IN THE TREATMENT OF THROMBOTIC MICROANGIOPATHY ASSOCIATED WITH COVID-19 INFECTION: A CASE REPORT
por: Logan, Danielle, et al.
Publicado: (2020)

THE ROLE OF ASCORBIC ACID IN REDUCING MORTALITY IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: KHOKHER, WALEED, et al.
Publicado: (2021)

OUTCOMES OF PATIENTS WITH COVID-19 ON ANTIHYPERTENSIVE MEDICATIONS IN SOUTHERN PENNSYLVANIA
por: CHAN, VERNON, et al.
Publicado: (2021)

PROTEINACEOUS COVID-19
por: Chandna, Sanya, et al.
Publicado: (2020)

THE BENEFITS OF CORTICOSTEROIDS IN COVID-19 WITH ORGANIZING PNEUMONIA-LIKE PATTERN: A CLINICAL REPORT OF SUCCESSFUL TREATMENT
por: ARGEL, MARIANA, et al.
Publicado: (2021)

EFFECT OF AMANTADINE TREATMENT AND STANDARD OF CARE VS STANDARD OF CARE ON MORTALITY AMONG PATIENTS HOSPITALIZED FOR COVID-19
por: MONTALVAN, ELEAZAR, et al.
Publicado: (2021)

POST-COVID-19 ASPERGILLOSIS
por: BAIG, MARIA HAIDER
Publicado: (2022)

MACROGLOSSIA IN THE SETTING OF COVID-19
por: HASSANIN, ES-HAQ, et al.
Publicado: (2022)

SEX-SPECIFIC OCCUPATIONAL AND CLINICAL CHARACTERISTICS OF CRITICALLY ILL PATIENTS WITH COVID-19 IN NEW YORK CITY
por: Karpel, Hannah, et al.
Publicado: (2020)

CAVITATION DUE TO COVID-19: A CASE OF SECONDARY ATYPICAL MYCOBACTERIAL INFECTION POST-COVID-19
por: BHAGAT, MILIND, et al.
Publicado: (2021)

SIGNIFICANT REDUCTION IN MORTALITY RATE IN CRITICALLY ILL PATIENTS WITH COVID-19 WITH THE IMPLEMENTATION OF A TREATMENT PROTOCOL-EXPERIENCE OF A TERTIARY CARE CENTER IN MIDWESTERN UNITED STATES DURING THE FIRST PEAK OF THE COVID-19 PANDEMIC
por: GUPTA, SANDEEP, et al.
Publicado: (2021)

COVID-19-INDUCED AORTIC THROMBOSIS
por: DOUEDI, STEVEN, et al.
Publicado: (2021)

LETHAL FUNGEMIA IN COVID-19 PNEUMONIA
por: PLEMMONS, ANNA, et al.
Publicado: (2021)

NOCARDIA AFTER COVID-19 INFECTION
por: ARIF, MUHAMMAD, et al.
Publicado: (2021)

INCIDENCE OF COINFECTION IN PATIENTS WITH COVID-19
por: Aleman, Valeria Demeneghi, et al.
Publicado: (2020)

POST-COVID-19 EOSINOPHILIC PNEUMONIA
por: SHAH, DHIRAJ, et al.
Publicado: (2022)

HEMOLYTIC ANEMIA AND METHEMOGLOBINEMIA DUE TO HYDROXYCHLOROQUINE USE FOR COVID-19 TREATMENT IN A GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT PATIENT
por: Lim, Steven, et al.
Publicado: (2020)

NOT EVERYTHING IS COVID: PERSISTENT FEVER AND MALAISE MIMICKING COVID-19 PNEUMONIA
por: ATUAKA, CHRISTIANA, et al.
Publicado: (2021)

RETROSPECTIVE REVIEW OF MELATONIN IN PATIENTS WITH COVID-19
por: SAHU, NITASA, et al.
Publicado: (2021)

COMPLICATIONS OF HIGH-DOSE STEROIDS IN COVID-19
por: KAUR, TANISHA, et al.
Publicado: (2021)

GUILLAIN-BARRÉ SYNDROME AND HEMOLYSIS IN COVID-19
por: FERNANDES, MATEUS, et al.
Publicado: (2021)

LEGIONELLA INFECTION IN THE MIDST OF COVID-19 PANDEMIC
por: GANDHI, KEJAL, et al.
Publicado: (2021)

HYPERCOAGULABLE STATE: AN ENIGMA IN COVID-19 INFECTION
por: MILI, SAIMA, et al.
Publicado: (2021)

POSTPARTUM COVID-19 COMPLICATED BY BLASTOMYCOSIS INFECTION
por: NASIM, RABAB, et al.
Publicado: (2021)

ANCHORING BIAS DURING THE COVID-19 PANDEMIC
por: PATEL, NISHA, et al.
Publicado: (2021)

COVID-19 COMPLICATED BY THE INVASION OF ASPERGILLUS TERREUS
por: SIRIPHAND, CHRISTOPHER, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qgjttbjevpk0kerau5nmt22a13